ONCOZENE
LIVE

Serial Number

85872453

Owner

CeloNova Biosciences, Inc.

Attorney

Kelly P. McCarthy

First Use Date

Jun 5, 2013

Filing Date

Mar 11, 2013

Add to watchlist:

No watchlists yet
View on USPTO

ONCOZENE Trademark

Serial Number: 85872453 • Registration: 4544651

ONCOZENE is a trademark filed by CeloNova Biosciences, Inc. on March 11, 2013. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

CeloNova Biosciences, Inc. (43 trademarks)

Suite 100
Peachtree City, GA 30269

Entity Type: 03

BOSTON SCIENTIFIC LIMITED (33 trademarks)

The Financial Services Centre
St. Michael BB14004 , BB

Entity Type: 03

VARIAN MEDICAL SYSTEMS, INC. (190 trademarks)

3100 HANSEN WAY
PALO ALTO, CA 94304

Entity Type: 03

Trademark Details

Filing Date

March 11, 2013

Registration Date

June 3, 2014

First Use Anywhere

June 5, 2013

First Use in Commerce

June 5, 2013

Published for Opposition

November 26, 2013

Goods & Services

Medical products, namely, embolic microspheres for use in endovascular therapy, for treatment of hypervascularized tumors and to control and prevent abnormal bleeding; Medical products, namely, embolic microspheres for embolization in the form of particles; Medical products, namely, embolic microspheres in the form of particles to slow or block blood flow for mediating devascularizations; Medical products, namely, embolic microspheres in the form of particles to block blood flow throughout the vasculature system; Medical products, namely, embolic microspheres in the form of particles to treat hemorrhages, arteriovenous malformations, hemangioendothelioma, cerebral aneurysms, muscle hypertrophy, hypertrophic cardiomyopathy, gastrointestinal bleeding, trauma, epistaxis, bone cysts, bone metastases, vertebral metastases, varicoceles, congenital hemangioma, artiovenous fistulae, vena cava, vascular anomalies, priapism, prostatic hematuria, hemoptysis, hemorrhagic cystitis, and post-partum hemorrhage; Medical products, namely, embolic microspheres in the form of particles to prevent or reduce blood flow through any tissue or organ of interest in order to reduce the growths of hypervascular tissues or malignant cells, tumors, lesions, hepatocellular carcinoma, and fibroids; Medical products, namely, embolic microspheres in the form of particles to treat vascular conditions; Medical products, namely, embolic microspheres in the form of embolic particle implants; Medical products, namely, embolic microspheres for treating vascular anomalies of the body

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Aug 19, 2024 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Aug 19, 2024 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Aug 19, 2024 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 19, 2024 APRE
TEAS SECTION 8 & 9 RECEIVED
Jun 3, 2024 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jun 3, 2023 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jul 22, 2020 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jul 22, 2020 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 21, 2020 APRE
TEAS SECTION 8 & 15 RECEIVED
May 5, 2020 E815
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 5, 2020 ASGN
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 6, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 6, 2019 REAP
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 3, 2019 REM1
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 27, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 27, 2016 REAP
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 27, 2016 ASGN
REGISTERED-PRINCIPAL REGISTER
Jun 3, 2014 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 30, 2014 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
Apr 29, 2014 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 28, 2014 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 15, 2014 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 7, 2014 AITU
USE AMENDMENT FILED
Mar 13, 2014 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 13, 2014 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 21, 2014 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 26, 2013 NPUB
PUBLISHED FOR OPPOSITION
Nov 26, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 6, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 21, 2013 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 18, 2013 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 2, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 2, 2013 CRFA
ASSIGNED TO LIE
Oct 2, 2013 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 1, 2013 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 21, 2013 GNRN
NON-FINAL ACTION E-MAILED
Jun 21, 2013 GNRT
NON-FINAL ACTION WRITTEN
Jun 21, 2013 CNRT
ASSIGNED TO EXAMINER
Jun 20, 2013 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 30, 2013 TCCA
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 14, 2013 NWOS
NEW APPLICATION ENTERED
Mar 14, 2013 NWAP